Skip to main content

Table 1 Baseline characteristics of 24 men undergoing RARP

From: Hemodynamic, renal and hormonal effects of lung protective ventilation during robot-assisted radical prostatectomy, analysis of secondary outcomes from a randomized controlled trial

Characteristics

Total

HTV-l.PEEP

LTV-h.PEEP

P-value

Number

24

12

12

 

Age, yeara

64 (6.6)

64 (6.4)

66 (6.9)

0.526

Height, cma

178 (5)

180 (5)

177 (4)

0.105

Weight, kga

86.2 (10.7)

88.7 (12.9)

83.8 (7.8)

0.270

BMIa

27.2 (2.9)

27.4 (3.0)

26.9 (2.8)

0.678

Office blood pressure

 sBP, mmHga

152 (17)

149 (16)

156 (19)

0.344

 dBP, mmHga

90 (8)

92 (7)

88 (10)

0.294

 Pulsea

67 (11)

71 (11)

63 (10)

0.092

Comorbiditiesb

 Hypertension

8 (33.3)

3 (25.0)

5 (41.7)

0.667

 Heart disease

1 (4.2)

1 (8.3)

0

1.000

 Diabetes mellitus

2 (8.3)

2 (16.7)

0

0.478

 Stroke

0

0

0

1.000

Coexisting conditionsa

 Current smoking

3 (12.5)

2 (16.7)

1 (8.3)

1.000

 Previous smoking

11 (45.8)

4 (33.3)

7 (58.3)

0.414

 Any alcohol intake

20 (83.3)

10 (83.3)

10 (83.3)

1.000

Risk assessment, preoperative

 Gleason scorec

7 (6;7)

7 (7;7)

7 (6;7)

0.870

 PSAa

8.7 (4.1)

9.9 (4.2)

7.5 (3.9)

0.169

 pT stagec

7 (7;7)

7 (7;7)

7 (7;7)

1.000

  1. HTV-l.PEEP High tidal volume, low positive end-expiratory pressure, LTV-h.PEEP Low tidal volume, low positive end-expiratory pressure, BMI Body mass index = weight (kg)/height (cm)2, sBP Systolic blood pressure, dBP Diastolic blood pressure, PSA Prostate specific antigen, pT stage Pathological tumor stage
  2. aParametric data; shown as means ± SD; unpaired t test used to test difference between groups
  3. bNorminal data; shown as number (%); Fisher’s exact test used to test difference between groups
  4. cNon-parametric data; shown as medians [25–75% quartiles]; Mann-Whitney U test used to test difference between groups